Arkolith/Insider Trading/PAND/Form 4

Kakkar Rahul

Chief Executive Officer, DirectorPandion Therapeutics, Inc. (PAND) · full profile →Form 4 · filed Apr 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2021Tender(U)14K$60.00$840K0
Apr 1, 2021Tender(U)703K$60.00$42.2M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2021Disposed to issuer(D)221K——0
Apr 1, 2021Disposed to issuer(D)349K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-014453) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML